Luff Enterprises Announces Final Health Canada License Approval for the NG Biomed Group of Companies

Vancouver, B.C. – Luff Enterprises Ltd., (CSE: LUFF) (“LUFF” or the “Company”) is pleased to provide a further update on its previously announced agreement to acquire the National Green Biomed group of companies (“NG Biomed”). On July 21, 2022 Luff announced its plan to acquire, largely for share consideration, NG Biomed, a licensed producer of cannabis products for both the recreational and medical consumer markets.

Luff announces that NG Biomed’s wholly owned subsidiary, Rosebud Productions Inc., has received final approval from Health Canada to authorize the activity of sale of cannabis extracts, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers and holders of a licence for sale for medical purposes.

This approval was the final step in NG Biomed’s licence approval process, and will allow for a complete product offering for clients. It will also facilitate more streamlined procurement and fulfilment operations when medical sales are initiated. 

Luff’s CEO, Philip Campbell, remarked, “The sales licence approval for extracts is the culmination of months of hard work and determination by the team at National Green Biomed, with a relentless focus on quality and consistency. With our new sales platform for medical products in Canada ramping up, this approval paves the way for Luff to expand the products that we are bringing to market, in addition to our proposed best-in-class craft flower menu.”

The acquisition of NG Biomed remains subject to approval from NG Biomed’s shareholders, approval from the Canadian Securities Exchange, if needed, and completion of customary closing conditions.

ABOUT LUFF ENTERPRISES LTD.

LUFF is a hemp and wellness company, focused on providing premium quality, innovative products across the United States through its online store. Committed to plant-based science, LUFF produces and sources a suite of thoughtfully designed products to benefit a wide range of user needs.

Currently, the Company focuses on identifying unique products and formulations leveraging cannabinoids to empower people to realize the full potential of everyday life. LUFF’s scientifically formulated products are non-GMO, THC-free, 3rd party tested, and only crafted with hemp grown in the United States.

FOR FURTHER INFORMATION:

Philip Campbell, CEO and Director
Email: IR@luffbrands.com
Telephone: 250-419-7665